Navigation Links
Five States Step Up Efforts to Screen Newborns for Cystic Fibrosis
Date:7/11/2008

More Than 40 States Now Provide Routine Testing for Life-Threatening Disease

WASHINGTON, July 11 /PRNewswire-USNewswire/ -- Four states -- Arkansas, Kansas, Maine, and West Virginia -- have joined 40 others and the District of Columbia in requiring that all newborns be screened for cystic fibrosis (CF) at birth.

In addition, Utah has cleared the way to begin regular CF screening as well. Routine screening is expected to begin January 1, 2009.

"Newborn screening for cystic fibrosis is critically important because it allows doctors to diagnose the disease before a child becomes ill," said Robert J. Beall, Ph.D., president and CEO of the Cystic Fibrosis Foundation. "Early diagnosis leads to a better chance for a healthier and longer life. Each of these states has taken an important step in the fight against cystic fibrosis."

Research studies show that newborn screening for CF will likely improve and extend the lives of those born with the disease. Early diagnosis allows affected infants to begin therapeutic interventions immediately. In research studies, these interventions have been shown to improve height, weight, nutrition, cognitive and lung functioning, and to reduce hospitalizations.

Cystic fibrosis is a fatal genetic disease that affects 30,000 children and adults in the United States and 70,000 people worldwide. It causes thick mucus to build up in the lungs and other organs, resulting in life-threatening infections and serious digestive complications.

Newborn screening for cystic fibrosis is important because more than 10 million Americans are symptomless carriers of a cystic fibrosis gene. Additionally, most people who have a child with CF are not aware of a family history of the disease.

When the Cystic Fibrosis Foundation was created in 1955, few children lived to attend elementary school. Today, as a result of dramatic improvements in research and care fueled by the Foundation, the median age of survival for a person with CF is 37 years.

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization in the United States devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation has more than 80 chapters and branch offices throughout the country and supports and accredits a nationwide network of 115 care centers, which provide vital treatments and other CF resources to patients and families. For more information, visit http://www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New CDC Report Demonstrates Urgency for All States and Cities to Become Smokefree
2. 4 Million Babies Born Each Year in United States; $8 Million That Shows You Care About All of Them!
3. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
4. Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy
5. The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called The Strength to Heal That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio.
6. The American Red Cross Urges Safety in States Affected by Flooding
7. Tainted Tomato Cases Jump to 383 People in 30 states, D.C.
8. 2 More States, Part of Mexico Ruled Out as Salmonella Source
9. 228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak
10. Most States Fail to Protect Consumers Against Insurance Company Abuses
11. American Red Cross Responds to Floods and Tornadoes in Central United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... Sept. 27, 2017  Commended for their devotion to personalized ... Ranked as number one in the South Florida Business Journal,s ... Inc. 5000 yearly list, the national specialty pharmacy has found ... Bardisa will soon be honored by SFBJ as the ... Set to receive his award in October, Bardisa ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: